Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.11-25

The United States market has shown robust performance, climbing by 2.2% over the past week with all sectors experiencing gains, and achieving a 32% increase over the last 12 months, while earnings are...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486443080?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/._HFmWFPcwt6muyT_tZE7g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b394072c431426666ba19d9f9857f297","is_english":true,"pubTime":"2024-11-25 22:15","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2486443080","market":"us","top_or_hot":-1,"title":"Exploring Three High Growth Tech Stocks In The United States","media":"Simply Wall St.","content":"<div>\n<p>The United States market has shown robust performance, climbing by 2.2% over the past week with all sectors experiencing gains, and achieving a 32% increase over the last 12 months, while earnings are...</p>\n\n<a href=\"https://finance.yahoo.com/news/exploring-three-high-growth-tech-141525525.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Exploring Three High Growth Tech Stocks In The United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExploring Three High Growth Tech Stocks In The United States\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-25 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/exploring-three-high-growth-tech-141525525.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The United States market has shown robust performance, climbing by 2.2% over the past week with all sectors experiencing gains, and achieving a 32% increase over the last 12 months, while earnings are...</p>\n\n<a href=\"https://finance.yahoo.com/news/exploring-three-high-growth-tech-141525525.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1571399168.USD","symbol_name":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/exploring-three-high-growth-tech-141525525.html","article_id":"2486443080","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/._HFmWFPcwt6muyT_tZE7g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b394072c431426666ba19d9f9857f297"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486443080","pubTimestamp":1732544125,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The United States market has shown robust performance, climbing by 2.2% over the past week with all sectors experiencing gains, and achieving a 32% increase over the last 12 months, while earnings are projected to grow by 15% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these favorable market conditions.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 250 stocks from our US High Growth Tech and AI Stocks screener.Overview: Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the discovery, development, and commercialization of novel therapeutics using ribonucleic acid interference technology, with a market cap of $31.59 billion.Overview: Gilead Sciences, Inc. is a biopharmaceutical company that focuses on discovering, developing, and commercializing medicines for unmet medical ne","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","BK4532":"文艺复兴科技持仓","BK4585":"ETF&股票定投概念","UBCP":"联合合众银行","LU0234570918.USD":"高盛全球核心股票组合Acc Close","IE00BF5LJ272.USD":"Legg Mason Martin Currie - Global Emerging Markets A Acc USD","BK4139":"生物科技","GILD":"吉利德科学","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4566":"资本集团","BK4211":"区域性银行","BK4578":"CAR-T","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","BK4588":"碎股","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","GLOB":"Globant","ALNY":"阿尔尼拉姆制药公司","BK4134":"信息科技咨询与其它服务","LU0058720904.USD":"联博国际健康护理基金A","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","IE00B0169N27.USD":"STEWARD INVESTORS GLOBAL EMERGING MARKETS LEADERS \"I\" (USD) ACC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK4548":"巴美列捷福持仓","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","BK4583":"猴痘概念","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B"},"translate_title":"探索美国三只高增长科技股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UBCP":1,"GLOB":1,"ALNY":0.9,"GILD":0.67},"content_text":"The United States market has shown robust performance, climbing by 2.2% over the past week with all sectors experiencing gains, and achieving a 32% increase over the last 12 months, while earnings are projected to grow by 15% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these favorable market conditions.\nTop 10 High Growth Tech Companies In The United States\n\n\n\nName\nRevenue Growth\nEarnings Growth\nGrowth Rating\n\n\nSuper Micro Computer\n23.83%\n24.32%\n★★★★★★\n\n\nSarepta Therapeutics\n23.90%\n42.65%\n★★★★★★\n\n\nClene\n78.50%\n60.16%\n★★★★★★\n\n\nTG Therapeutics\n34.66%\n56.48%\n★★★★★★\n\n\nAlkami Technology\n21.89%\n98.60%\n★★★★★★\n\n\nAlnylam Pharmaceuticals\n22.45%\n70.66%\n★★★★★★\n\n\nTravere Therapeutics\n31.70%\n72.51%\n★★★★★★\n\n\nBlueprint Medicines\n25.47%\n68.62%\n★★★★★★\n\n\nSeagen\n22.57%\n71.80%\n★★★★★★\n\n\nImmunoGen\n26.00%\n45.85%\n★★★★★★\n\n\n\nClick here to see the full list of 250 stocks from our US High Growth Tech and AI Stocks screener.\nHere we highlight a subset of our preferred stocks from the screener.\nAlnylam Pharmaceuticals\nSimply Wall St Growth Rating: ★★★★★★\nOverview: Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the discovery, development, and commercialization of novel therapeutics using ribonucleic acid interference technology, with a market cap of $31.59 billion.\nOperations: Alnylam focuses on ribonucleic acid interference therapeutics, generating revenue primarily from its discovery, development, and commercialization activities, totaling $2.09 billion.\nAlnylam Pharmaceuticals is navigating a transformative phase with anticipated revenue growth of 22.4% annually, outpacing the US market's average of 8.9%. Despite current unprofitability, the firm is on a trajectory to profitability within three years, supported by robust R&D investments that fuel innovation in RNAi therapeutics. Recent presentations at global healthcare conferences underscore Alnylam's commitment to advancing treatments for ATTR amyloidosis, with promising Phase 3 study results potentially enhancing future revenue streams and strengthening its market position in biotechnology.\n\nGet an in-depth perspective on Alnylam Pharmaceuticals' performance by reading our health report here.\nReview our historical performance report to gain insights into Alnylam Pharmaceuticals''s past performance.\n\n\n\n\n  NasdaqGS:ALNY Revenue and Expenses Breakdown as at Nov 2024\n \n\nGilead Sciences\nSimply Wall St Growth Rating: ★★★★☆☆\nOverview: Gilead Sciences, Inc. is a biopharmaceutical company that focuses on discovering, developing, and commercializing medicines for unmet medical needs globally, with a market cap of $112.40 billion.\nOperations: Gilead generates revenue primarily through the discovery, development, and commercialization of innovative medicines, amounting to $28.30 billion. The company operates across the United States, Europe, and internationally.\nGilead Sciences, with a projected annual earnings growth rate of 40.7%, is navigating through a transformative phase despite recent financial setbacks including a significant one-off loss of $10.3B. The company's commitment to innovation is underscored by its R&D focus, where expenses are strategically aligned to foster developments in biotechnology and pharmaceuticals. Recent clinical trial successes, such as the promising results from the Phase 3 ASSURE study for Livdelzi®, highlight Gilead’s potential to enhance its therapeutic offerings and market position significantly. These efforts are part of why Gilead remains a notable entity in the high-growth sectors of tech and healthcare, even as it faces challenges like underperforming revenue growth projections at 2.4% annually compared to broader market averages.\n\nClick to explore a detailed breakdown of our findings in Gilead Sciences' health report.\nLearn about Gilead Sciences' historical performance.\n\n\n\n\n  NasdaqGS:GILD Revenue and Expenses Breakdown as at Nov 2024\n \n\nGlobant\nSimply Wall St Growth Rating: ★★★★☆☆\nOverview: Globant S.A., along with its subsidiaries, offers technology services globally and has a market cap of $9.89 billion.\nOperations: Globant generates revenue primarily from its Software & Programming segment, which brought in $2.35 billion. The company focuses on providing a range of technology services worldwide.\nGlobant stands out in the tech landscape with its robust revenue growth, projected at 13.2% annually, surpassing the US market average of 8.9%. This growth is complemented by a significant uptick in earnings, expected to rise by 20.1% per year. The company's strategic emphasis on R&D is evident from its recent allocation of substantial resources towards innovation, ensuring it remains at the forefront of technological advancements and competitive within the digital transformation space. Recent collaborations, like with Qiddiya Investment Company to enhance Saudi Arabia’s Qiddiya City through advanced digital ecosystems, underscore Globant’s capability to integrate AI and cloud technologies effectively across global markets. This approach not only solidifies its market position but also aligns with broader industry trends towards immersive technology experiences and smart city developments.\n\nClick here to discover the nuances of Globant with our detailed analytical health report.\nUnderstand Globant's track record by examining our Past report.\n\n\n\n\n  NYSE:GLOB Revenue and Expenses Breakdown as at Nov 2024\n \n\nNext Steps\n\nClick through to start exploring the rest of the 247 US High Growth Tech and AI Stocks now.\nAlready own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.\nTake control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.\n\nReady To Venture Into Other Investment Styles?\n\nExplore high-performing small cap companies that haven't yet garnered significant analyst attention.\nFuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.\nFind companies with promising cash flow potential yet trading below their fair value.\n\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nCompanies discussed in this article include NasdaqGS:ALNY NasdaqGS:GILD and NYSE:GLOB.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486443080"}